AdAlta Investor Relations Material
Latest events
Study Update
AdAlta
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AdAlta Limited
Access all reports
AdAlta Limited is an Australian biotechnology company focused on the discovery and development of novel protein-based therapeutics. The company utilizes its proprietary i-body technology platform to create next-generation biologic drugs targeting a range of diseases, including fibrosis and immune-related conditions. AdAlta Limited is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for AdAlta Limited
Investor Presentation
AdAlta Limited
Investor Update
AdAlta Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
1AD
Country
🇦🇺 Australia